{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:45:29Z","timestamp":1785386729915,"version":"3.55.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2IK6BX004854"],"award-info":[{"award-number":["2IK6BX004854"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IO1BX004446"],"award-info":[{"award-number":["IO1BX004446"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The testis-specific protein Y-linked (TSPY) is a male-specific cancer-testis antigen specifically expressed in germ cells of the testis under normal conditions and various cancers, particularly in hepatocellular carcinoma (HCC), under oncogenic conditions. It binds to cyclin B and exacerbates the cyclin B-CDK1 phosphorylation of factors important for mitotic\/meiotic divisions. To determine if such TSPY proliferative actions could contribute to various male-biases in liver cancer, TSPY transgene was expressed in an oncogene-induced preclinical mouse model of HCC, using the hydrodynamic tail vein injection strategy. The results showed that TSPY expression suppressed tumor cell growth at early stage but could evolve to resume oncogenic progression at late stage in this mouse model. Transcriptome and bioinformatic analyses demonstrated that significant immune and inflammatory responses were activated in early stage of the cancer, resulting in elimination of positive tumor cells. Significant TSPY antibodies were present in the sera of positive mice, similar to the presence of autoantibodies in the sera of patients positive for TSPY in their tumors. Flow cytometry and cellular protein fractionation analyses of positive tumor cells showed that TSPY protein could be mislocalized on the cell surface and likely be responsible for the humoral immunity. Additional studies demonstrated that TSPY peptides were produced and could form complexes with MHC-I molecules and be presented on the cell surface, thereby eliciting robust cytotoxic T cell responses and killing of positive tumor cells. Importantly these immune responses diminished and TSPY could exacerbate oncogenic growth at late stage. These findings suggest that as a male-specific cancer-testis antigen, TSPY is extremely immunogenic capable of eliciting robust immune and inflammatory responses at the early stage and is a significant candidate for development of immunotherapeutics, such as therapeutic cancer vaccine and antibody-drug conjugates, in treatments of hepatocellular carcinoma in men.<\/jats:p>","DOI":"10.1186\/s13578-025-01432-8","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:20:02Z","timestamp":1750850402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The human testis-specific protein Y-linked (TSPY) is a male-specific cancer-testis antigen capable of eliciting significant immune responses and elimination of positive tumor cells in hepatocellular carcinoma"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-5517","authenticated-orcid":false,"given":"Tatsuo","family":"Kido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9119-7050","authenticated-orcid":false,"given":"Yun-Fai Chris","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"1432_CR1","doi-asserted-by":"crossref","unstructured":"Nin DS, Deng LW. Biology of Cancer-Testis antigens and their therapeutic implications in Cancer. Cells 2023, 12(6).","DOI":"10.3390\/cells12060926"},{"key":"1432_CR2","doi-asserted-by":"crossref","unstructured":"Ramchatesingh B, Gantchev J, Villarreal AM, Gill RPK, Lambert M, Sivachandran S, Lefrancois P, Litvinov IV. The contributions of Cancer-Testis and developmental genes to the pathogenesis of keratinocyte carcinomas. Cancers (Basel) 2022, 14(15).","DOI":"10.3390\/cancers14153630"},{"key":"1432_CR3","doi-asserted-by":"crossref","unstructured":"Ren S, Zhang Z, Li M, Wang D, Guo R, Fang X, Chen F. Cancer testis antigen subfamilies: attractive targets for therapeutic vaccine (Review). Int J Oncol 2023, 62(6).","DOI":"10.3892\/ijo.2023.5519"},{"key":"1432_CR4","doi-asserted-by":"publisher","first-page":"103214","DOI":"10.1016\/j.dnarep.2021.103214","volume":"108","author":"A Jay","year":"2021","unstructured":"Jay A, Reitz D, Namekawa SH, Heyer WD. Cancer testis antigens and genomic instability: more than immunology. DNA Repair (Amst). 2021;108:103214.","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"1432_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/biolre\/ioab074","volume":"105","author":"CH Kern","year":"2021","unstructured":"Kern CH, Yang M, Liu WS. The PRAME family of cancer testis antigens is essential for germline development and Gametogenesisdagger. Biol Reprod. 2021;105(2):290\u2013304.","journal-title":"Biol Reprod"},{"issue":"1\u20132","key":"1432_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/19396368.2010.499157","volume":"57","author":"YF Lau","year":"2011","unstructured":"Lau YF, Li Y, Kido T. Role of the Y-located putative gonadoblastoma gene in human spermatogenesis. Syst Biol Reprod Med. 2011;57(1\u20132):27\u201334.","journal-title":"Syst Biol Reprod Med"},{"issue":"10","key":"1432_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.trecan.2018.08.005","volume":"4","author":"ZA Gibbs","year":"2018","unstructured":"Gibbs ZA, Whitehurst AW. Emerging contributions of cancer\/testis antigens to neoplastic behaviors. Trends Cancer. 2018;4(10):701\u201312.","journal-title":"Trends Cancer"},{"issue":"24","key":"1432_CR8","doi-asserted-by":"publisher","first-page":"10362","DOI":"10.1158\/0008-5472.CAN-10-1341","volume":"70","author":"L Marcar","year":"2010","unstructured":"Marcar L, Maclaine NJ, Hupp TR, Meek DW. Mage-A cancer\/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res. 2010;70(24):10362\u201370.","journal-title":"Cancer Res"},{"key":"1432_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2019.10.024","volume":"479","author":"R Wei","year":"2020","unstructured":"Wei R, Dean DC, Thanindratarn P, Hornicek FJ, Guo W, Duan Z. Cancer testis antigens in sarcoma: expression, function and immunotherapeutic application. Cancer Lett. 2020;479:54\u201360.","journal-title":"Cancer Lett"},{"issue":"3","key":"1432_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/1008-682X.150842","volume":"17","author":"T Kido","year":"2015","unstructured":"Kido T, Lau YF. Roles of the Y chromosome genes in human cancers. Asian J Androl. 2015;17(3):373\u201380.","journal-title":"Asian J Androl"},{"issue":"9","key":"1432_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/imt-2017-0179","volume":"10","author":"AM Mahmoud","year":"2018","unstructured":"Mahmoud AM. Cancer testis antigens as Immunogenic and oncogenic targets in breast cancer. Immunotherapy. 2018;10(9):769\u201378.","journal-title":"Immunotherapy"},{"key":"1432_CR12","doi-asserted-by":"crossref","unstructured":"Vogt PH, Affara N, Davey P, Hammer M, Jobling MA, Lau YF, Mitchell M, Schempp W, Tyler-Smith C, Williams G et al. Report of the Third International Workshop on Y Chromosome Mapping 1997. Heidelberg, Germany, April 13\u201316, 1997. Cytogenet Cell Genet 1997, 79(1\u20132):1\u201320.","DOI":"10.1159\/000134680"},{"issue":"7978","key":"1432_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41586-023-06457-y","volume":"621","author":"A Rhie","year":"2023","unstructured":"Rhie A, Nurk S, Cechova M, Hoyt SJ, Taylor DJ, Altemose N, Hook PW, Koren S, Rautiainen M, Alexandrov IA, et al. The complete sequence of a human Y chromosome. Nature. 2023;621(7978):344\u201354.","journal-title":"Nature"},{"issue":"7978","key":"1432_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41586-023-06425-6","volume":"621","author":"P Hallast","year":"2023","unstructured":"Hallast P, Ebert P, Loftus M, Yilmaz F, Audano PA, Logsdon GA, Bonder MJ, Zhou W, Hops W, Kim K, et al. Assembly of 43 human Y chromosomes reveals extensive complexity and variation. Nature. 2023;621(7978):355\u201364.","journal-title":"Nature"},{"key":"1432_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1242\/dev.101.Supplement.151","volume":"101","author":"DC Page","year":"1987","unstructured":"Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development. 1987;101:151\u20135.","journal-title":"Development"},{"issue":"4","key":"1432_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1086\/302353","volume":"64","author":"YF Lau","year":"1999","unstructured":"Lau YF. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet. 1999;64(4):921\u20137.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1432_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/path.1587","volume":"203","author":"F Honecker","year":"2004","unstructured":"Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol. 2004;203(3):849\u201357.","journal-title":"J Pathol"},{"issue":"1","key":"1432_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/bdrc.20144","volume":"87","author":"YF Lau","year":"2009","unstructured":"Lau YF, Li Y, Kido T. Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res C Embryo Today. 2009;87(1):114\u201322.","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"47","key":"1432_CR19","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1038\/onc.2008.206","volume":"27","author":"Y Li","year":"2008","unstructured":"Li Y, Lau YF. TSPY and its X-encoded homologue interact with Cyclin B but exert contrasting functions on Cyclin-dependent kinase 1 activities. Oncogene. 2008;27(47):6141\u201350.","journal-title":"Oncogene"},{"issue":"3","key":"1432_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4103\/aja.aja_43_18","volume":"21","author":"YC Lau","year":"2019","unstructured":"Lau YC, Li Y, Kido T. Battle of the sexes: contrasting roles of testis-specific protein Y-encoded (TSPY) and TSPX in human oncogenesis. Asian J Androl. 2019;21(3):260\u20139.","journal-title":"Asian J Androl"},{"issue":"10","key":"1432_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jgg.2016.09.003","volume":"43","author":"T Kido","year":"2016","unstructured":"Kido T, Lau YC. Identification of a TSPY co-expression network associated with DNA hypomethylation and tumor gene expression in somatic cancers. J Genet Genomics. 2016;43(10):577\u201385.","journal-title":"J Genet Genomics"},{"issue":"3\u20134","key":"1432_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000074345","volume":"101","author":"YF Lau","year":"2003","unstructured":"Lau YF, Lau HW, Komuves LG. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res. 2003;101(3\u20134):250\u201360.","journal-title":"Cytogenet Genome Res"},{"key":"1432_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2407-6-154","volume":"6","author":"SW Oram","year":"2006","unstructured":"Oram SW, Liu XX, Lee TL, Chan WY, Lau YF. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer. 2006;6:154.","journal-title":"BMC Cancer"},{"issue":"5","key":"1432_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/hmg\/ddx005","volume":"26","author":"Y Li","year":"2017","unstructured":"Li Y, Zhang DJ, Qiu Y, Kido T, Lau YC. The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants. Hum Mol Genet. 2017;26(5):901\u201312.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1432_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R","volume":"27","author":"YF Lau","year":"2000","unstructured":"Lau YF, Zhang J. Expression analysis of Thirty one Y chromosome genes in human prostate cancer. Mol Carcinog. 2000;27(4):308\u201321.","journal-title":"Mol Carcinog"},{"issue":"9","key":"1432_CR26","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.humpath.2014.05.002","volume":"45","author":"T Kido","year":"2014","unstructured":"Kido T, Lo RC, Li Y, Lee J, Tabatabai ZL, Ng IO, Lau YF. The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma. Hum Pathol. 2014;45(9):1847\u201358.","journal-title":"Hum Pathol"},{"issue":"7","key":"1432_CR27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1055-9965.EPI-20-0036","volume":"29","author":"M Dong","year":"2020","unstructured":"Dong M, Cioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, Lathia JD, Rubin JB, Berens ME, Connor J, et al. Sex differences in Cancer incidence and survival: A Pan-Cancer analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1389\u201397.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1432_CR28","doi-asserted-by":"crossref","unstructured":"Selvaraj RC, Cioffi G, Waite KA, Jackson SS, Barnholtz-Sloan JS. A Pan-Cancer analysis of age and sex differences in Cancer incidence and survival in the united states, 2001\u20132020. Cancers (Basel) 2025, 17(3).","DOI":"10.3390\/cancers17030378"},{"issue":"3","key":"1432_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.24736","volume":"55","author":"C Ho","year":"2012","unstructured":"Ho C, Wang C, Mattu S, Destefanis G, Ladu S, Delogu S, Armbruster J, Fan L, Lee SA, Jiang L, et al. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma Ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of Rapamycin complex 1), FOXM1 (forkhead box M1)\/SKP2, and c-Myc pathways. Hepatology. 2012;55(3):833\u201345.","journal-title":"Hepatology"},{"key":"1432_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13578-019-0287-x","volume":"9","author":"T Kido","year":"2019","unstructured":"Kido T, Lau YC. The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression. Cell Biosci. 2019;9:22.","journal-title":"Cell Biosci"},{"issue":"1","key":"1432_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41389-023-00449-3","volume":"12","author":"T Kido","year":"2023","unstructured":"Kido T, Lau YC. Androgen receptor variant 7 exacerbates hepatocarcinogenesis in a c-MYC-driven mouse HCC model. Oncogenesis. 2023;12(1):4.","journal-title":"Oncogenesis"},{"issue":"1","key":"1432_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/crispr.2020.0090","volume":"4","author":"D Bloemberg","year":"2021","unstructured":"Bloemberg D, Sosa-Miranda CD, Nguyen T, Weeratna RD, McComb S. Self-Cutting and integrating CRISPR plasmids enable targeted genomic integration of genetic payloads for rapid cell engineering. CRISPR J. 2021;4(1):104\u201319.","journal-title":"CRISPR J"},{"issue":"1","key":"1432_CR33","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1002\/cpmb.117","volume":"130","author":"CG Johnson","year":"2020","unstructured":"Johnson CG, Chen T, Furey N, Hemmingsen MG, Bissig KD. Somatic liver knockout (SLiK): A quick and efficient way to generate liver-Specific knockout mice using multiplex CRISPR\/Cas9 gene editing. Curr Protoc Mol Biol. 2020;130(1):e117.","journal-title":"Curr Protoc Mol Biol"},{"issue":"1","key":"1432_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbrc.2006.08.191","volume":"350","author":"T Kido","year":"2006","unstructured":"Kido T, Lau YF. The rat Tspy is preferentially expressed in elongated spermatids and interacts with the core histones. Biochem Biophys Res Commun. 2006;350(1):56\u201367.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1432_CR35","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1038\/s41598-017-04117-6","volume":"7","author":"T Kido","year":"2017","unstructured":"Kido T, Sun Z, Lau YC. Aberrant activation of the human sex-determining gene in early embryonic development results in postnatal growth retardation and lethality in mice. Sci Rep. 2017;7(1):4113.","journal-title":"Sci Rep"},{"issue":"15","key":"1432_CR36","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.18632\/oncotarget.26673","volume":"10","author":"T Kido","year":"2019","unstructured":"Kido T, Li Y, Tanaka Y, Dahiya R, Chris Lau YF. The X-linked tumor suppressor TSPX downregulates cancer-drivers\/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner. Oncotarget. 2019;10(15):1491\u2013506.","journal-title":"Oncotarget"},{"issue":"8","key":"1432_CR37","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1111\/cas.14506","volume":"111","author":"T Kido","year":"2020","unstructured":"Kido T, Tabatabai ZL, Chen X, Lau YC. Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. Cancer Sci. 2020;111(8):2987\u201399.","journal-title":"Cancer Sci"},{"issue":"15","key":"1432_CR38","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"1","key":"1432_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"7","key":"1432_CR40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"key":"1432_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1471-2105-14-219","volume":"14","author":"J Sun","year":"2013","unstructured":"Sun J, Nishiyama T, Shimizu K, Kadota K. TCC: an R package for comparing Tag count data with robust normalization strategies. BMC Bioinformatics. 2013;14:219.","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"1432_CR42","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1432_CR43","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, Chen J, Jiang W, Yang K, Ou Q, et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51(D1):D870\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1432_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-1759(95)00238-3","volume":"189","author":"HJ Schuberth","year":"1996","unstructured":"Schuberth HJ, Kroell A, Leibold W. Biotinylation of cell surface MHC molecules: a complementary tool for the study of MHC class II polymorphism in cattle. J Immunol Methods. 1996;189(1):89\u201398.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1432_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41592-024-02517-x","volume":"22","author":"C Brown","year":"2025","unstructured":"Brown C, Ghosh S, McAllister R, Kumar M, Walker G, Sun E, Aman T, Panda A, Kumar S, Li W, et al. A proteome-wide quantitative platform for nanoscale spatially resolved extraction of membrane proteins into native nanodiscs. Nat Methods. 2025;22(2):412\u201321.","journal-title":"Nat Methods"},{"issue":"1","key":"1432_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbrc.2014.02.083","volume":"446","author":"T Kido","year":"2014","unstructured":"Kido T, Lau YF. The Y-located gonadoblastoma gene TSPY amplifies its own expression through a positive feedback loop in prostate cancer cells. Biochem Biophys Res Commun. 2014;446(1):206\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1432_CR47","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/ijc.23697","volume":"123","author":"T Kido","year":"2008","unstructured":"Kido T, Lau YF. The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein. Int J Cancer. 2008;123(7):1573\u201385.","journal-title":"Int J Cancer"},{"issue":"4","key":"1432_CR48","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/hep.31120","volume":"72","author":"A Bisso","year":"2020","unstructured":"Bisso A, Filipuzzi M, Gamarra Figueroa GP, Brumana G, Biagioni F, Doni M, Ceccotti G, Tanaskovic N, Morelli MJ, Pendino V, et al. Cooperation between MYC and beta-Catenin in liver tumorigenesis requires yap\/taz. Hepatology. 2020;72(4):1430\u201343.","journal-title":"Hepatology"},{"issue":"5","key":"1432_CR49","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3.","journal-title":"Genome Biol"},{"issue":"D1","key":"1432_CR50","doi-asserted-by":"publisher","first-page":"D853","DOI":"10.1093\/nar\/gkac816","volume":"51","author":"S Jiang","year":"2023","unstructured":"Jiang S, Qian Q, Zhu T, Zong W, Shang Y, Jin T, Zhang Y, Chen M, Wu Z, Chu Y, et al. Cell taxonomy: a curated repository of cell types with multifaceted characterization. Nucleic Acids Res. 2023;51(D1):D853\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1432_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/path.1711730404","volume":"173","author":"R Chetty","year":"1994","unstructured":"Chetty R, Gatter K. CD3: structure, function, and role of immunostaining in clinical practice. J Pathol. 1994;173(4):303\u20137.","journal-title":"J Pathol"},{"issue":"4","key":"1432_CR52","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/sj.bjc.6602716","volume":"93","author":"YH Yin","year":"2005","unstructured":"Yin YH, Li YY, Qiao H, Wang HC, Yang XA, Zhang HG, Pang XW, Zhang Y, Chen WF. TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer. 2005;93(4):458\u201363.","journal-title":"Br J Cancer"},{"issue":"25","key":"1432_CR53","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1056\/NEJMra072739","volume":"358","author":"OJ Finn","year":"2008","unstructured":"Finn OJ. Cancer immunology. N Engl J Med. 2008;358(25):2704\u201315.","journal-title":"N Engl J Med"},{"issue":"4","key":"1432_CR54","first-page":"1079","volume":"27","author":"T Himoto","year":"2005","unstructured":"Himoto T, Kuriyama S, Zhang JY, Chan EK, Kimura Y, Masaki T, Uchida N, Nishioka M, Tan EM. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Int J Oncol. 2005;27(4):1079\u201385.","journal-title":"Int J Oncol"},{"key":"1432_CR55","doi-asserted-by":"crossref","unstructured":"Jeffery CJ. Protein moonlighting: what is it, and why is it important? Philos Trans R Soc Lond B Biol Sci 2018, 373(1738).","DOI":"10.1098\/rstb.2016.0523"},{"issue":"1","key":"1432_CR56","first-page":"13","volume":"1846","author":"X Wang","year":"2014","unstructured":"Wang X, Li S. Protein mislocalization: mechanisms, functions and clinical applications in cancer. Biochim Biophys Acta. 2014;1846(1):13\u201325.","journal-title":"Biochim Biophys Acta"},{"key":"1432_CR57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev.immunol.17.1.739","volume":"17","author":"KL Rock","year":"1999","unstructured":"Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol. 1999;17:739\u201379.","journal-title":"Annu Rev Immunol"},{"key":"1432_CR58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molimm.2018.05.009","volume":"99","author":"J Valecka","year":"2018","unstructured":"Valecka J, Almeida CR, Su B, Pierre P, Gatti E. Autophagy and MHC-restricted antigen presentation. Mol Immunol. 2018;99:163\u201370.","journal-title":"Mol Immunol"},{"key":"1432_CR59","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","volume":"8","author":"M Wieczorek","year":"2017","unstructured":"Wieczorek M, Abualrous ET, Sticht J, Alvaro-Benito M, Stolzenberg S, Noe F, Freund C. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol. 2017;8:292.","journal-title":"Front Immunol"},{"key":"1432_CR60","doi-asserted-by":"publisher","first-page":"101419","DOI":"10.1016\/j.smim.2020.101419","volume":"49","author":"JR Conejo-Garcia","year":"2020","unstructured":"Conejo-Garcia JR, Biswas S, Chaurio R. Humoral immune responses: unsung heroes of the war on cancer. Semin Immunol. 2020;49:101419.","journal-title":"Semin Immunol"},{"issue":"2","key":"1432_CR61","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, Gogenur I. Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367.","journal-title":"Br J Cancer"},{"issue":"9","key":"1432_CR62","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","volume":"20","author":"K Yang","year":"2023","unstructured":"Yang K, Halima A, Chan TA. Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy. Nat Rev Clin Oncol. 2023;20(9):604\u201323.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1432_CR63","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13577-018-0212-3","volume":"31","author":"F Kasai","year":"2018","unstructured":"Kasai F, Hirayama N, Ozawa M, Satoh M, Kohara A. HuH-7 reference genome profile: complex karyotype composed of massive loss of heterozygosity. Hum Cell. 2018;31(3):261\u20137.","journal-title":"Hum Cell"},{"issue":"20","key":"1432_CR64","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1158\/0008-5472.CAN-20-1418","volume":"80","author":"Y Su","year":"2020","unstructured":"Su Y, Zhang X, Bidlingmaier S, Behrens CR, Lee NK, Liu B. ALPPL2 is a highly specific and targetable tumor cell surface antigen. Cancer Res. 2020;80(20):4552\u201364.","journal-title":"Cancer Res"},{"issue":"4","key":"1432_CR65","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/gene.20147","volume":"42","author":"T Kido","year":"2005","unstructured":"Kido T, Lau YF. A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons. Genesis. 2005;42(4):263\u201375.","journal-title":"Genesis"},{"issue":"2","key":"1432_CR66","first-page":"64","volume":"10","author":"J deBlaquiere","year":"1999","unstructured":"deBlaquiere J, Burgess AW. Affinity purification of plasma membranes. J Biomol Tech. 1999;10(2):64\u201371.","journal-title":"J Biomol Tech"},{"issue":"1","key":"1432_CR67","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","volume":"22","author":"X Wu","year":"2023","unstructured":"Wu X, Li T, Jiang R, Yang X, Guo H, Yang R. Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Mol Cancer. 2023;22(1):194.","journal-title":"Mol Cancer"},{"issue":"11","key":"1432_CR68","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock KL, Reits E, Neefjes J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 2016;37(11):724\u201337.","journal-title":"Trends Immunol"},{"key":"1432_CR69","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul S, Lal G. The molecular mechanism of natural killer cells function and its importance in Cancer immunotherapy. Front Immunol. 2017;8:1124.","journal-title":"Front Immunol"},{"issue":"6","key":"1432_CR70","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","volume":"105","author":"I Prager","year":"2019","unstructured":"Prager I, Watzl C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. J Leukoc Biol. 2019;105(6):1319\u201329.","journal-title":"J Leukoc Biol"},{"issue":"4960","key":"1432_CR71","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1126\/science.2112266","volume":"248","author":"BH Koller","year":"1990","unstructured":"Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta 2\u00a0M, MHC class I proteins, and CD8\u2009+\u2009T cells. Science. 1990;248(4960):1227\u201330.","journal-title":"Science"},{"issue":"7522","key":"1432_CR72","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature13589","volume":"514","author":"W Xue","year":"2014","unstructured":"Xue W, Chen S, Yin H, Tammela T, Papagiannakopoulos T, Joshi NS, Cai W, Yang G, Bronson R, Crowley DG, et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature. 2014;514(7522):380\u20134.","journal-title":"Nature"},{"issue":"9","key":"1432_CR73","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/hmg\/1.9.717","volume":"1","author":"JS Zhang","year":"1992","unstructured":"Zhang JS, Yang-Feng TL, Muller U, Mohandas TK, de Jong PJ, Lau YF. Molecular isolation and characterization of an expressed gene from the human Y chromosome. Hum Mol Genet. 1992;1(9):717\u201326.","journal-title":"Hum Mol Genet"},{"key":"1432_CR74","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jgg.2011.04.002","volume":"38","author":"T Kido","year":"2011","unstructured":"Kido T, Schubert S, Schmidtke J, Lau YF. Expression of the human TSPY gene in the brains of Transgenic mice suggests a potential role of this Y chromosome gene in neural functions. J Genet Genomics. 2011;38:181\u201392.","journal-title":"J Genet Genomics"},{"issue":"3","key":"1432_CR75","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1095\/biolreprod.103.016501","volume":"69","author":"S Schubert","year":"2003","unstructured":"Schubert S, Skawran B, Dechend F, Nayernia K, Meinhardt A, Nanda I, Schmid M, Engel W, Schmidtke J. Generation and characterization of a Transgenic mouse with a functional human TSPY. Biol Reprod. 2003;69(3):968\u201375.","journal-title":"Biol Reprod"},{"issue":"1","key":"1432_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-3701-4-9","volume":"4","author":"T Kido","year":"2014","unstructured":"Kido T, Schubert S, Hatakeyama S, Ohyama C, Schmidtke J, Lau YF. Expression of a Y-located human proto-oncogene TSPY in a Transgenic mouse model of prostate cancer. Cell Biosci. 2014;4(1):9.","journal-title":"Cell Biosci"},{"issue":"4","key":"1432_CR77","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s003350010054","volume":"11","author":"S Schubert","year":"2000","unstructured":"Schubert S, Dechend F, Skawran B, Kunze B, Winking H, Weile C, Romer I, Hemberger M, Fundele R, Sharma T, et al. Silencing of the Y-chromosomal gene Tspy during murine evolution. Mamm Genome. 2000;11(4):288\u201391.","journal-title":"Mamm Genome"},{"key":"1432_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13578-020-00452-w","volume":"10","author":"YC Lau","year":"2020","unstructured":"Lau YC. Y chromosome in health and diseases. Cell Biosci. 2020;10:97.","journal-title":"Cell Biosci"},{"key":"1432_CR79","doi-asserted-by":"publisher","first-page":"868695","DOI":"10.3389\/fphar.2022.868695","volume":"13","author":"SK Kim","year":"2022","unstructured":"Kim SK, Cho SW. The evasion mechanisms of Cancer immunity and drug intervention in the tumor microenvironment. Front Pharmacol. 2022;13:868695.","journal-title":"Front Pharmacol"},{"key":"1432_CR80","doi-asserted-by":"publisher","first-page":"1204363","DOI":"10.3389\/fimmu.2023.1204363","volume":"14","author":"Q Guan","year":"2023","unstructured":"Guan Q, Han M, Guo Q, Yan F, Wang M, Ning Q, Xi D. Strategies to reinvigorate exhausted CD8(+) T cells in tumor microenvironment. Front Immunol. 2023;14:1204363.","journal-title":"Front Immunol"},{"key":"1432_CR81","doi-asserted-by":"publisher","first-page":"102429","DOI":"10.1016\/j.ctrv.2022.102429","volume":"109","author":"N Sobhani","year":"2022","unstructured":"Sobhani N, Scaggiante B, Morris R, Chai D, Catalano M, Tardiel-Cyril DR, Neeli P, Roviello G, Mondani G, Li Y. Therapeutic cancer vaccines: from biological mechanisms and engineering to ongoing clinical trials. Cancer Treat Rev. 2022;109:102429.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"1432_CR82","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","volume":"22","author":"C Dumontet","year":"2023","unstructured":"Dumontet C, Reichert JM, Senter PD, Lambert JM, Beck A. Antibody-drug conjugates come of age in oncology. Nat Rev Drug Discov. 2023;22(8):641\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"1432_CR83","doi-asserted-by":"crossref","unstructured":"Emens LA, Romero PJ, Anderson AC, Bruno TC, Capitini CM, Collyar D, Gulley JL, Hwu P, Posey AD Jr., Silk AW et al. Challenges and opportunities in cancer immunotherapy: a society for immunotherapy of Cancer (SITC) strategic vision. J Immunother Cancer 2024, 12(6).","DOI":"10.1136\/jitc-2024-009063"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T12:02:26Z","timestamp":1750852946000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-025-01432-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01432-8","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were approved by the Institutional Committee on Animal Care and Usage at the San Francisco VA Health Care System. No human research was conducted in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}